Chris Procyshyn is the Chief Executive Officer of Vanrx Pharmasystems, a founder, and member of its Board of Directors. With over twenty years’ experience in the pharmaceutical industry, Chris has led teams in the development of complex injectable products in the fields of ophthalmology, oncology and reproductive health. Globally experienced, he has interacted with, and negotiated the implementation of new technologies with many of the major regulatory jurisdictions responsible for pharmaceuticals and medical devices. Previously with QLT, a pioneering Canadian biopharmaceutical company, Chris led the Manufacturing, Engineering and Process Sciences groups in the development of many advanced aseptic processes and their implementation into manufacturing facilities in multiple countries. Chris is a past Vice President of the ISPE Pacific Northwest Chapter, and is a graduate of the University of Saskatchewan with a Bachelor of Science degree in Microbiology.